Human natural killer cell line modified with a chimeric immunoglobulin T-cell receptor gene leads to tumor growth inhibition in vivo (Q40737432)

23 September 2017

Human natural killer cell line modified with a chimeric immunoglobulin T-cell receptor gene leads to tumor growth inhibition in vivo (English)

1 reference

23 September 2017

0 references

Thomas Schirrmann

1

1 reference

PubMed ID

11960290

23 September 2017

Gabriele Pecher

series ordinal

2

1 reference

23 September 2017

1 April 2002

1 reference

23 September 2017

1 reference

23 September 2017

9

1 reference

23 September 2017

4

1 reference

23 September 2017

390-398

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700453

23 September 2017

0 references

cites work

An improved linker for single-chain Fv with reduced aggregation and enhanced proteolytic stability.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700453

Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700453

A retroviral vector system 'STITCH' in combination with an optimized single chain antibody chimeric receptor gene structure allows efficient gene transduction and expression in human T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700453

T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700453

Lysis of ovarian cancer cells by human lymphocytes redirected with a chimeric gene composed of an antibody variable region and the Fc receptor gamma chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700453

A chimeric receptor that selectively targets membrane-bound carcinoembryonic antigen (mCEA) in the presence of soluble CEA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700453

Specific targeting of EGP-2+ tumor cells by primary lymphocytes modified with chimeric T cell receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700453

NK cell activation: distinct stimulatory pathways counterbalancing inhibitory signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700453

Natural cytotoxicity receptors that trigger human NK-cell-mediated cytolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700453

Characterization of genetically altered, interleukin 2-independent natural killer cell lines suitable for adoptive cellular immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700453

Restoration of lytic function in a human natural killer cell line by gene transfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700453

The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700453

5 Humanization of monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700453

Characterisation of a humanised bispecific monoclonal antibody for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700453

Characterization of the epitope recognized by a monoclonal antibody directed against the largest subunit of Drosophila RNA polymerase II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700453

The nucleotide sequence of a human immnnoglobulin Cγlgene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700453

Targeting vectors for intracellular immunisation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700453

T cell activation by recombinant FcepsilonRI gamma-chain immune receptors: an extracellular spacer domain impairs antigen-dependent T cell activation but not antigen recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700453

Double suicide gene (cytosine deaminase and herpes simplex virus thymidine kinase) but not single gene transfer allows reliable elimination of tumor cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700453

Tumor-specific T-bodies: towards clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700453

7 January 2021

Single-chain antigen-binding proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700453

7 January 2021

Anti-tumor activity of human T cells expressing the CC49-zeta chimeric immune receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700453

7 January 2021

Dynamics of tumor cell killing by human T lymphocytes armed with an anti-carcinoembryonic antigen chimeric immunoglobulin T-cell receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700453

7 January 2021

Quantitative considerations supporting the irrelevance of circulating serum CEA for the immunoscintigraphic visualization of CEA expressing carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700453

7 January 2021

99Tcm-labelled anti-CEA monoclonal antibody for tumour immunoscintigraphy: first clinical results

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700453

7 January 2021

Growth of tumor-infiltrating lymphocytes from human solid cancers: summary of a 5-year experience

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700453

7 January 2021

Binding reactivity of monoclonal anti-carcinoembryonic antigen (CEA) antibodies with cell membrane-bound CEA and with free CEA in solution

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700453

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7700453

1 reference

PubMed ID

11960290

Dimensions Publication ID

23 September 2017

0 references

1 reference

PubMed ID

11960290